- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Empagliflozin 10 MG
Total 12461 results
-
Damanhour UniversityRecruitingHeart Failure | Reduced Ejection Fraction Heart FailureEgypt
-
Medical University of WarsawMedical University of Graz; Medical University of Vienna; Poznan University of... and other collaboratorsRecruitingAcute Decompensated Heart FailurePoland
-
AstraZenecaNot yet recruitingHeart Failure and Impaired Kidney FunctionUnited States, Canada, Finland, France, Germany, Italy, Spain, United Kingdom, Thailand, Vietnam, Korea, Republic of, Mexico, Peru, Philippines, Turkey, China, Taiwan, Austria, Slovakia, Chile, Argentina, Japan, Czechia, Greece, Hungary, ... and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Ain Shams UniversityNot yet recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Dong-A ST Co., Ltd.CompletedType2 DiabetesKorea, Republic of
-
Boehringer IngelheimCompleted
-
National Taiwan University HospitalRecruitingVentilator Lung | Heart Failure AcuteTaiwan
-
Collegium Medicum w BydgoszczyRecruitingMetabolic SyndromePoland
-
University of Mississippi Medical CenterEli Lilly and CompanyRecruiting
-
AstraZenecaCompleted
-
Butler HospitalNational Institute of Mental Health (NIMH)CompletedSubstance-Related Disorders | Depression | HIV InfectionsUnited States
-
Yale UniversityBoehringer IngelheimRecruitingEnd Stage Renal Disease on DialysisUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedAcute Myeloid LeukemiaUnited States
-
Medical University of ViennaVienna Dialysis CenterRecruitingDiabetes Mellitus, Type 2 | Hemodialysis | Chronic Kidney Disease | Kidney Failure | Left Ventricular HypertrophyAustria
-
Centro Universitario de Ciencias de la Salud, MexicoActive, not recruitingDiabetes Mellitus Type 2 Without ComplicationMexico
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Completed
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Completed
-
Fundación Pública Andaluza para la Investigación...Unknown
-
The University of Hong KongResearch Grant CouncilRecruitingCirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 InhibitorsHong Kong
-
The University of Hong KongFood and Health Bureau, Hong KongCompletedNon-alcoholic Fatty Liver DiseaseHong Kong
-
AstraZenecaCompletedBioequivalence | Fixed Dose Combination Tablets | Healthy Male and Female SubjectsUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
AstraZenecaTerminatedType 2 Diabetes MellitusThailand, Vietnam
-
AstraZenecaParexelCompletedType 2 Diabetes MellitusUnited States
-
Anita SarafThe Pittsburgh FoundationNot yet recruitingHeart Failure | Adult Congenital Heart DiseaseUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Stanford UniversityCompletedLiver Cirrhosis | Cirrhosis | Ascites | Ascites Hepatic | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection FractionChina
-
Amsterdam UMC, location VUmcRecruitingIdiopathic Pulmonary Arterial HypertensionNetherlands
-
University of Texas Southwestern Medical CenterBoehringer IngelheimCompletedDiabetes Mellitus | Heart Failure, Diastolic | Heart Failure With Preserved Ejection FractionUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection FractionChina
-
Rajaie Cardiovascular Medical and Research CenterTehran Heart CenterRecruitingCABG | Post-operative Atrial FibrillationIran, Islamic Republic of
-
Yale UniversityRecruiting
-
Sadat City UniversityRecruitingUlcerative ColitisEgypt
-
NHS Greater Glasgow and ClydeUniversity of GlasgowNot yet recruitingMyocardial InfarctionUnited Kingdom
-
Juntendo UniversityBoehringer IngelheimRecruiting
-
Jacob MollerRigshospitalet, Denmark; University Hospital Bispebjerg and Frederiksberg; Hillerod... and other collaboratorsRecruitingHeart Failure | ObesityDenmark
-
Mario Negri Institute for Pharmacological ResearchBoehringer IngelheimWithdrawnObesity | Non-diabetic Chronic Kidney Disease
-
Chulalongkorn UniversityNot yet recruitingEmpagliflozin in Cardiorenal Syndrome Type 1Thailand
-
Chinese University of Hong KongRecruitingAcute Heart FailureHong Kong
-
Chulalongkorn UniversityRecruitingEmpagliflozin in Post AKI Stage 2-3Thailand
-
Jacob MollerRigshospitalet, Denmark; University Hospital Bispebjerg and Frederiksberg; Hillerod... and other collaboratorsRecruitingHeart Failure | ObesityDenmark
-
Mutah UniversityCompletedPharmacokinetic ParametersJordan
-
Morten SchouCompletedHeart Failure With Reduced Ejection FractionDenmark
-
Medical University of ViennaCompletedPosttransplant Diabetes MellitusAustria
-
Washington D.C. Veterans Affairs Medical CenterNot yet recruiting
-
Ain Shams UniversityNot yet recruiting
-
Alexandria UniversityRecruitingHeart Failure With Reduced Ejection FractionEgypt